RSV can probably be useful as an inhibitor of unwanted PARP1 hyper-activation in the prevention and/or in the treatment of some metabolic and inflammatory diseases such as cardiovascular, Parkinson’s, and Alzheimer’s diseases, neurodegenerative disorders, and diabetes [15,20,58]. Here, PARP1 is linked to early-onset autosomal dominant Alzheimer disease.